Injection Site Amyloidosis
Injection site amyloidosis, most commonly insulin-derived amyloidosis (AIns), is a localized, secondary form of amyloid deposition in the deep dermis and subcutaneous fat. It develops after exogenous peptides – especially insulin in people with type 1 or type 2 diabetes – are injected repeatedly into the same anatomical site over a long period.
At Haute-Derma, we see many patients who come in with infiltrated lumps under the skin of the abdomen or thighs that have long been misdiagnosed as injection-related lipohypertrophy. Correctly identifying injection site amyloidosis does more than improve the appearance of the skin: it is critical for restoring insulin absorption, controlling blood glucose and preventing acute hypoglycemia.
Pathophysiology and Origin of AIns Amyloid Fibrils
Amyloid builds up at the injection site through a series of local protein changes:
- Local accumulation: repeatedly injecting insulin (or peptides such as enfuvirtide or GLP-1 agonists) into a small area of skin drives the drug concentration in the tissue above its physiological solubility limit.
- Repeated micro-trauma: the repeated needle punctures create low-grade chronic inflammation and release free radicals in the subcutaneous stroma.
- Denaturation and misfolding: under the influence of this inflammatory microenvironment and the high concentration, insulin molecules lose their normal monomer/hexamer structure and self-assemble into abnormal oligomers.
- Formation of AIns amyloid fibrils: the oligomers link up into amyloid fibrils with a very stable parallel β-pleated sheet structure that resists breakdown by the body's own proteases and settles as a firm mass under the skin.
Clinical Features and Impact on Blood Glucose Control
Skin Findings
- Subcutaneous lumps or infiltrated plaques: round lumps or raised plaques with a rubbery or cartilage-hard base and a fairly well-defined border.
- Common sites: most often around the navel, the lower abdomen on either side, the front and outer thighs, and the upper arms – the areas patients find easiest to inject themselves.
- Surface changes: the skin over the AIns mass may look normal or smooth and shiny, or show faint, wavy hyperpigmentation. It is usually painless and non-itchy unless a large mass causes pressure.
Serious Effects on Insulin Pharmacokinetics
- Persistent absorption barrier: the AIns deposit acts as a "biological trap," reducing insulin absorption into the bloodstream by up to 50–90%.
- Insulin pseudoresistance: patients keep having to raise their dose (sometimes to more than 100 IU/day), yet their HbA1c stays high because the insulin is not reaching the blood.
- Sudden hypoglycemia: if the patient happens to inject into nearby healthy skin instead, the large, previously escalated dose is fully absorbed and can cause severe, dangerous episodes of acute hypoglycemia.
Differential Diagnosis: Injection Site Amyloidosis vs. Lipohypertrophy
| Insulin-Derived Amyloidosis (AIns) | Lipohypertrophy | Primary Nodular Amyloidosis |
|---|---|---|
| Very firm, rubbery or cartilage-like | Soft and spongy, like normal fat | Moderately firm, smooth nodules |
| Deposits of AIns amyloid fibrils | Enlarged fat cells (adipocytes) | Infiltration by AL amyloid fibrils |
| Caused by long-term insulin injection at the same site | Yes (caused by not rotating injection sites) | Not related to injections |
| Hypoechoic or mixed-echo plaque with irregular margins | Uniform hyperechoic fatty mass | Hypoechoic plaque infiltrating the deep dermis |
| Congo red positive (apple-green birefringence) | Congo red negative | Congo red positive (apple-green birefringence) |
Our Diagnostic Workup at Haute-Derma
Injection site amyloidosis is confirmed through a standardized, step-by-step process:
- Clinical examination and injection history: the usual injection areas are examined carefully, the firmness of any lumps is assessed, and findings are compared with the patient's glucose log (looking for unexplained swings in blood sugar).
- High-frequency skin ultrasound (HFUS): a 20–50 MHz probe is used to assess the dermis and subcutis. AIns appears as a localized hypoechoic plaque without abnormal vascularity, which quickly distinguishes it from lipohypertrophy or a vascular tumor.
- Skin biopsy (4 mm punch or excisional biopsy): a sample including the full thickness of the dermis and subcutaneous fat is taken from the firmest part of the lesion.
- Special stains and immunohistochemistry
- Congo red stain: brick-red staining with apple-green birefringence under polarized light.
- Immunohistochemistry (IHC): anti-insulin antibodies specifically identify insulin protein within the amyloid fibrils, confirming the diagnosis of AIns.
Treatment and Our Role in Care at Haute-Derma
Managing AIns requires endocrine care and skin restoration to go hand in hand:
- Stop injecting into the affected site and urgently adjust the insulin dose: injections are moved immediately to completely healthy skin. The doctor must proactively reduce the insulin dose by 20–50% as soon as the injection site is changed, to avoid hypoglycemia once the drug starts being absorbed normally again.
- Training in proper site rotation: patients are taught to rotate injection sites (dividing the abdomen into 4 quadrants, injecting at least 2 cm from the previous site, and not reusing any spot within 4 weeks).
- Surgical excision of the AIns mass or micro-liposuction: for large, hardened AIns masses that are cosmetically troubling or keep blocking absorption, complete surgical removal of the deposit or micro-liposuction is the only definitive option, because AIns fibrils do not break down on their own.
- Skin repair and regeneration at Haute-Derma
- HFUS assessment and follow-up: skin ultrasound at Haute-Derma is used to track the regression of scar tissue and the density of the dermis after surgery.
- Fractional laser and radiofrequency (RF): stimulate collagen remodeling, smooth uneven skin, and reduce fibrosis and surface hyperpigmentation after the AIns mass has been removed.
- Supporting the dermal matrix: treatments that nourish the skin's microcirculation help the affected area regain its natural elasticity.
